Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.66 |
| ▸ | NPY2R | P49146 | 7/20 | 0.63 |
| ▸ | NPY4R | P50391 | 7/20 | 0.63 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.63 |
| ▸ | NPY1R | P25929 | 5/20 | 0.63 |
| ▸ | TFPI | P10646 | 4/20 | 0.60 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.58 |
| ▸ | EP300 | Q09472 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30618027 | 0.94 | NPY2R (0.67) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31651397 | 0.90 | NPY2R (0.71) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30658279 | 0.89 | NPY2R (0.73) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30578733 | 0.89 | CALCR (0.73) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30578729 | 0.89 | CALCR (0.73) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30712788 | 0.89 | EP300 (0.56) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL31182542 | 0.89 | NPY2R (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29779564 | 0.89 | NPY2R (0.65) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30618034 | 0.89 | CALCR (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30658358 | 0.89 | CALCR (0.77) | CALCRNPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116987180-A | Methods and compositions for cancer diagnosis and treatment | 生物技术欧洲股份公司 | 2023-11-03 | — | — | CN | disclosed |